Stromal Vascular Fraction Market Size to Hit USD 5.02 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Stromal Vascular Fraction Market

5.1. COVID-19 Landscape: Stromal Vascular Fraction Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Stromal Vascular Fraction Market, By Type

8.1. Stromal Vascular Fraction Market Revenue and Volume, by Type

8.1.1. Autologous SVF

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Allogeneic SVF

8.1.2.1. Market Revenue and Volume Forecast

Chapter 9. Global Stromal Vascular Fraction Market, By Product/Component

9.1. Stromal Vascular Fraction Market Revenue and Volume, by Product/Component

9.1.1. SVF Isolation Systems (Devices & Kits)

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Enzymatic Reagents & Solutions

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Centrifuges & Consumables

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Culture Media

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Cryopreservation Equipment

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Software & Imaging Tools

9.1.6.1. Market Revenue and Volume Forecast

Chapter 10. Global Stromal Vascular Fraction Market, By Source of Tissue

10.1. Stromal Vascular Fraction Market Revenue and Volume, by Source of Tissue

10.1.1. Adipose Tissue

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Umbilical Cord Tissue

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Placental Tissue

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Bone Marrow

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Stromal Vascular Fraction Market, By Application

11.1. Stromal Vascular Fraction Market Revenue and Volume, by Application

11.1.1. Bone Marrow

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Aesthetic & Cosmetic Procedures

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Wound Healing & Dermatology

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Cardiovascular Diseases

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Autoimmune & Inflammatory Disorders

11.1.5.1. Market Revenue and Volume Forecast

11.1.6. Neurological Disorders

11.1.6.1. Market Revenue and Volume Forecast

11.1.7. Diabetes & Metabolic Diseases

11.1.7.1. Market Revenue and Volume Forecast

11.1.8. Others (e.g., pulmonary, renal, liver diseases)

11.1.8.1. Market Revenue and Volume Forecast

Chapter 12. Global Stromal Vascular Fraction Market, By End User

12.1. Stromal Vascular Fraction Market Revenue and Volume, by End User

12.1.1. Hospitals & Surgical Clinics

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Stem Cell & Regenerative Medicine Clinics

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Cosmetic & Dermatology Clinics

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Academic & Research Institutes

12.1.4.1. Market Revenue and Volume Forecast

12.1.5. Biotech & CROs

12.1.5.1. Market Revenue and Volume Forecast

Chapter 13. Global Stromal Vascular Fraction Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Type

13.1.2. Market Revenue and Volume Forecast, by Product/Component

13.1.3. Market Revenue and Volume Forecast, by Source of Tissue

13.1.4. Market Revenue and Volume Forecast, by Application

13.1.5. Market Revenue and Volume Forecast, by End User

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Type

13.1.6.2. Market Revenue and Volume Forecast, by Product/Component

13.1.6.3. Market Revenue and Volume Forecast, by Source of Tissue

13.1.6.4. Market Revenue and Volume Forecast, by Application

13.1.6.5. Market Revenue and Volume Forecast, by End User

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Type

13.1.7.2. Market Revenue and Volume Forecast, by Product/Component

13.1.7.3. Market Revenue and Volume Forecast, by Source of Tissue

13.1.7.4. Market Revenue and Volume Forecast, by Application

13.1.7.5. Market Revenue and Volume Forecast, by End User

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Type

13.2.2. Market Revenue and Volume Forecast, by Product/Component

13.2.3. Market Revenue and Volume Forecast, by Source of Tissue

13.2.4. Market Revenue and Volume Forecast, by Application

13.2.5. Market Revenue and Volume Forecast, by End User

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Type

13.2.6.2. Market Revenue and Volume Forecast, by Product/Component

13.2.6.3. Market Revenue and Volume Forecast, by Source of Tissue

13.2.7. Market Revenue and Volume Forecast, by Application

13.2.8. Market Revenue and Volume Forecast, by End User

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Type

13.2.9.2. Market Revenue and Volume Forecast, by Product/Component

13.2.9.3. Market Revenue and Volume Forecast, by Source of Tissue

13.2.10. Market Revenue and Volume Forecast, by Application

13.2.11. Market Revenue and Volume Forecast, by End User

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Type

13.2.12.2. Market Revenue and Volume Forecast, by Product/Component

13.2.12.3. Market Revenue and Volume Forecast, by Source of Tissue

13.2.12.4. Market Revenue and Volume Forecast, by Application

13.2.13. Market Revenue and Volume Forecast, by End User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Type

13.2.14.2. Market Revenue and Volume Forecast, by Product/Component

13.2.14.3. Market Revenue and Volume Forecast, by Source of Tissue

13.2.14.4. Market Revenue and Volume Forecast, by Application

13.2.15. Market Revenue and Volume Forecast, by End User

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Type

13.3.2. Market Revenue and Volume Forecast, by Product/Component

13.3.3. Market Revenue and Volume Forecast, by Source of Tissue

13.3.4. Market Revenue and Volume Forecast, by Application

13.3.5. Market Revenue and Volume Forecast, by End User

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Type

13.3.6.2. Market Revenue and Volume Forecast, by Product/Component

13.3.6.3. Market Revenue and Volume Forecast, by Source of Tissue

13.3.6.4. Market Revenue and Volume Forecast, by Application

13.3.7. Market Revenue and Volume Forecast, by End User

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Type

13.3.8.2. Market Revenue and Volume Forecast, by Product/Component

13.3.8.3. Market Revenue and Volume Forecast, by Source of Tissue

13.3.8.4. Market Revenue and Volume Forecast, by Application

13.3.9. Market Revenue and Volume Forecast, by End User

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Type

13.3.10.2. Market Revenue and Volume Forecast, by Product/Component

13.3.10.3. Market Revenue and Volume Forecast, by Source of Tissue

13.3.10.4. Market Revenue and Volume Forecast, by Application

13.3.10.5. Market Revenue and Volume Forecast, by End User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Type

13.3.11.2. Market Revenue and Volume Forecast, by Product/Component

13.3.11.3. Market Revenue and Volume Forecast, by Source of Tissue

13.3.11.4. Market Revenue and Volume Forecast, by Application

13.3.11.5. Market Revenue and Volume Forecast, by End User

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Type

13.4.2. Market Revenue and Volume Forecast, by Product/Component

13.4.3. Market Revenue and Volume Forecast, by Source of Tissue

13.4.4. Market Revenue and Volume Forecast, by Application

13.4.5. Market Revenue and Volume Forecast, by End User

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Type

13.4.6.2. Market Revenue and Volume Forecast, by Product/Component

13.4.6.3. Market Revenue and Volume Forecast, by Source of Tissue

13.4.6.4. Market Revenue and Volume Forecast, by Application

13.4.7. Market Revenue and Volume Forecast, by End User

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Type

13.4.8.2. Market Revenue and Volume Forecast, by Product/Component

13.4.8.3. Market Revenue and Volume Forecast, by Source of Tissue

13.4.8.4. Market Revenue and Volume Forecast, by Application

13.4.9. Market Revenue and Volume Forecast, by End User

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Type

13.4.10.2. Market Revenue and Volume Forecast, by Product/Component

13.4.10.3. Market Revenue and Volume Forecast, by Source of Tissue

13.4.10.4. Market Revenue and Volume Forecast, by Application

13.4.10.5. Market Revenue and Volume Forecast, by End User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Type

13.4.11.2. Market Revenue and Volume Forecast, by Product/Component

13.4.11.3. Market Revenue and Volume Forecast, by Source of Tissue

13.4.11.4. Market Revenue and Volume Forecast, by Application

13.4.11.5. Market Revenue and Volume Forecast, by End User

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Type

13.5.2. Market Revenue and Volume Forecast, by Product/Component

13.5.3. Market Revenue and Volume Forecast, by Source of Tissue

13.5.4. Market Revenue and Volume Forecast, by Application

13.5.5. Market Revenue and Volume Forecast, by End User

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Type

13.5.6.2. Market Revenue and Volume Forecast, by Product/Component

13.5.6.3. Market Revenue and Volume Forecast, by Source of Tissue

13.5.6.4. Market Revenue and Volume Forecast, by Application

13.5.7. Market Revenue and Volume Forecast, by End User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Type

13.5.8.2. Market Revenue and Volume Forecast, by Product/Component

13.5.8.3. Market Revenue and Volume Forecast, by Source of Tissue

13.5.8.4. Market Revenue and Volume Forecast, by Application

13.5.8.5. Market Revenue and Volume Forecast, by End User

Chapter 14. Company Profiles

14.1. Tissue Genesis (acquired by Orgenesis)

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Celltex Therapeutics

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. TissYou Biotech

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. XCellCure

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Pluristem Therapeutics

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Black Beret Life Sciences

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. VetStem Biopharma (animal SVF applications)

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Sanakin GmbH

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Lipogems International

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. BioRestorative Therapies

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The stromal vascular fraction market size is expected to increase from USD 1.54 billion in 2024 to USD 5.02 billion by 2034.

The stromal vascular fraction market is expected to grow at a compound annual growth rate (CAGR) of around 12.54% from 2025 to 2034.

The major players in the stromal vascular fraction market include InGeneron, Inc., Cytori Therapeutics, IntelliCell Biosciences, Human Med AG, Tissue Genesis, Celltex Therapeutics, Antria, GID Group, Inc., Ranfac Corp., LifeCell International, TissYou Biotech, Medikan International, XCellCure, Pluristem Therapeutics, VetStem Biopharma, Sanakin GmbH, Lipogems International, and BioRestorative Therapies.

The driving factors of the stromal vascular fraction market are the increased incidence of osteoarthritis, diabetes, and atherosclerotic heart disease has led to a greater need for new, innovative cell-based therapies (i.e., SVF) as potential long-term solutions in health care.

North America region will lead the global stromal vascular fraction market during the forecast period 2025 to 2034.